Correlation Between Sarepta Therapeutics and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Protara Therapeutics, you can compare the effects of market volatilities on Sarepta Therapeutics and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Protara Therapeutics.
Diversification Opportunities for Sarepta Therapeutics and Protara Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Sarepta and Protara is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Protara Therapeutics go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Protara Therapeutics
Given the investment horizon of 90 days Sarepta Therapeutics is expected to under-perform the Protara Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Sarepta Therapeutics is 1.07 times less risky than Protara Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Protara Therapeutics is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 528.00 in Protara Therapeutics on December 28, 2024 and sell it today you would lose (70.00) from holding Protara Therapeutics or give up 13.26% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sarepta Therapeutics vs. Protara Therapeutics
Performance |
Timeline |
Sarepta Therapeutics |
Protara Therapeutics |
Sarepta Therapeutics and Protara Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sarepta Therapeutics and Protara Therapeutics
The main advantage of trading using opposite Sarepta Therapeutics and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology | Protara Therapeutics vs. Xilio Development |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |